GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celltrion Inc (XKRX:068270) » Definitions » Cyclically Adjusted Price-to-FCF

Celltrion (XKRX:068270) Cyclically Adjusted Price-to-FCF : 240.86 (As of May. 16, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Celltrion Cyclically Adjusted Price-to-FCF?

As of today (2024-05-16), Celltrion's current share price is ₩193000.00. Celltrion's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was ₩801.31. Celltrion's Cyclically Adjusted Price-to-FCF for today is 240.86.

The historical rank and industry rank for Celltrion's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

XKRX:068270' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 147.24   Med: 680.6   Max: 9506.35
Current: 238.24

During the past years, Celltrion's highest Cyclically Adjusted Price-to-FCF was 9506.35. The lowest was 147.24. And the median was 680.60.

XKRX:068270's Cyclically Adjusted Price-to-FCF is ranked worse than
89.42% of 104 companies
in the Biotechnology industry
Industry Median: 55.165 vs XKRX:068270: 238.24

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Celltrion's adjusted free cash flow per share data for the three months ended in Dec. 2023 was ₩425.282. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ₩801.31 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Celltrion Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Celltrion's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celltrion Cyclically Adjusted Price-to-FCF Chart

Celltrion Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 694.02 1,717.19 254.67 237.22 251.46

Celltrion Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 237.22 200.95 161.73 173.67 251.46

Competitive Comparison of Celltrion's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, Celltrion's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Celltrion's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Celltrion's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Celltrion's Cyclically Adjusted Price-to-FCF falls into.



Celltrion Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Celltrion's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=193000.00/801.31
=240.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Celltrion's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Celltrion's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=425.282/118.8477*118.8477
=425.282

Current CPI (Dec. 2023) = 118.8477.

Celltrion Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 -384.350 99.253 -460.229
201406 -82.186 99.353 -98.312
201409 631.336 99.608 753.281
201412 -108.326 99.098 -129.915
201503 -238.852 99.720 -284.667
201506 -264.914 100.050 -314.687
201509 -239.637 100.110 -284.490
201512 25.558 100.220 30.308
201603 53.713 100.560 63.481
201606 -476.225 100.790 -561.546
201609 299.296 101.460 350.588
201612 739.962 101.560 865.919
201703 1,055.884 102.850 1,220.120
201706 395.235 102.610 457.780
201709 239.039 103.490 274.512
201712 1,013.328 102.990 1,169.353
201803 518.364 104.100 591.800
201806 259.834 104.130 296.559
201809 51.072 105.650 57.452
201812 392.229 104.350 446.723
201903 572.867 104.490 651.583
201906 114.990 104.880 130.304
201909 336.733 105.200 380.418
201912 256.291 105.120 289.760
202003 -27.654 105.540 -31.141
202006 328.940 104.870 372.783
202009 -364.306 106.200 -407.692
202012 -1,322.598 105.765 -1,486.192
202103 461.104 107.357 510.456
202106 900.931 107.579 995.306
202109 644.400 108.759 704.175
202112 2,135.083 109.676 2,313.622
202203 -331.012 111.806 -351.860
202206 -2,061.292 114.083 -2,147.386
202209 290.355 114.831 300.511
202212 30.990 115.200 31.971
202303 537.061 116.550 547.651
202306 1,349.993 117.140 1,369.675
202309 -1,032.478 119.111 -1,030.194
202312 425.282 118.848 425.282

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Celltrion  (XKRX:068270) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Celltrion Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Celltrion's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Celltrion (XKRX:068270) Business Description

Industry
Traded in Other Exchanges
N/A
Address
13-6 SongDo-Dong, Yeonsu-gu, Incheon City, KOR, 406-840
Celltrion Inc is a Korea-based company principally engaged in the research, development, and manufacture of therapeutic proteins. The company mainly manufactures biosimilar products, which are used to treat breast cancer, rheumatoid arthritis disease, Crohn's disease, Hodgkin's lymphoma, colorectal cancer, rheumatoid arthritis, respiratory syncytial virus, colon cancer, and others.

Celltrion (XKRX:068270) Headlines

No Headlines